LIFETECH SCI.DL-00000125 - Asset Resilience Ratio
LIFETECH SCI.DL-00000125 (81X) has an Asset Resilience Ratio of 8.59% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how LIFETECH SCI.DL-00000125's Asset Resilience Ratio has changed over time. See financial flexibility index of LIFETECH SCI.DL-00000125 to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down LIFETECH SCI.DL-00000125's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of LIFETECH SCI.DL-00000125.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €430.78 Million | 8.59% |
| Total Liquid Assets | €430.78 Million | 8.59% |
Asset Resilience Insights
- Limited Liquidity: LIFETECH SCI.DL-00000125 maintains only 8.59% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
LIFETECH SCI.DL-00000125 Industry Peers by Asset Resilience Ratio
Compare LIFETECH SCI.DL-00000125's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO |
Medical Devices | 10.80% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for LIFETECH SCI.DL-00000125 (2021–2025)
The table below shows the annual Asset Resilience Ratio data for LIFETECH SCI.DL-00000125.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 8.59% | €430.78 Million ≈ $503.63 Million |
€5.01 Billion ≈ $5.86 Billion |
-1.94pp |
| 2024-12-31 | 10.53% | €516.13 Million ≈ $603.41 Million |
€4.90 Billion ≈ $5.73 Billion |
+6.27pp |
| 2023-12-31 | 4.26% | €200.00 Million ≈ $233.82 Million |
€4.70 Billion ≈ $5.49 Billion |
-6.96pp |
| 2021-12-31 | 11.22% | €357.11 Million ≈ $417.50 Million |
€3.18 Billion ≈ $3.72 Billion |
-- |
About LIFETECH SCI.DL-00000125
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac P… Read more